- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 10.97M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 8.37M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1K |
| Capex | Q1 2026 · Mar 31, 2025 | $13K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.99M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.61M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.45M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.08M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $31.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.64M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.72M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.11M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.15M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.79M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.88M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $26.55M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.81M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $39.28M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.52M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.39 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.39 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.97M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.28M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.66M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.37M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $5.2M |